{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T09:16:20Z","timestamp":1789031780313,"version":"build-2803163510"},"reference-count":34,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,6,26]],"date-time":"2025-06-26T00:00:00Z","timestamp":1750896000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Public Health"],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Atherosclerotic cardiovascular disease (ASCVD) significantly threatens the health of the Chinese population. Understanding its epidemiological burden is vital for targeted interventions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Using Global Burden of Diseases (GBD) 2021 data, we assessed Disability-Adjusted Life Years (DALYs), incidence, prevalence, and mortality of ischemic heart disease (IHD), stroke, and lower extremity peripheral artery disease (PAD) in China in 2021. Joinpoint regression analyzed trends from 1990 to 2021, and risk factor contributions to the disease burden were evaluated.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Findings<\/jats:title>\n                    <jats:p>In 2021, age-standardized rates (ASRs) per 100,000 population for IHD (DALYs, incidence, prevalence, mortality) were 1856.5 (1548.7, 2159.8), 365.7 (293.3, 440.1), 3042.3 (2601.7, 3629.9), and 110.9 (92.4, 128.6), respectively, with males bearing a higher burden. For stroke, ASRs were 2648 (2253.4, 3076.9), 204.8 (181, 231.5), 1301.4 (1200.6, 1405.7), and 138 (116.7, 160.3), also higher in males. Lower extremity PAD showed ASRs of 8.4 (4.9, 14.3), 112.7 (97.8, 130.7), 1331.1 (1147.5, 1544.2), and 0.1 (0.1, 0.2), with a higher burden in females. Metabolic risks had the largest population-attributable fraction.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>As of 2021, the epidemiological burden of IHD, stroke, and PAD in China remains substantial, with notable gender disparities. Metabolic risks significantly contribute to this burden.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fpubh.2025.1529506","type":"journal-article","created":{"date-parts":[[2025,6,26]],"date-time":"2025-06-26T00:10:44Z","timestamp":1750896644000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":16,"title":["The epidemiology and burden of atherosclerotic cardiovascular disease in China from 1990 to 2021: findings from the global burden of disease 2021"],"prefix":"10.3389","volume":"13","author":[{"given":"Xin-Zheng","family":"Hou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying-Tian","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue-Jiao","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian-Yu","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen-Yan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-Yu","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shi-Han","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,6,26]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"2982","DOI":"10.1016\/j.jacc.2020.11.010","article-title":"Global burden of cardiovascular diseases and risk factors, 1990-2019: update from the GBD 2019 study","volume":"76","author":"Roth","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1161\/CIRCULATIONAHA.119.042864","article-title":"Time trends in cardiovascular disease mortality across the BRICS: an age-period-cohort analysis of key nations with emerging economies using the global burden of disease study 2017","volume":"141","author":"Zou","year":"2020","journal-title":"Circulation"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"e2351225","DOI":"10.1001\/jamanetworkopen.2023.51225","article-title":"National and provincial-level prevalence and risk factors of carotid atherosclerosis in chinese adults","volume":"7","author":"Fu","year":"2024","journal-title":"JAMA Netw Open"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"e968","DOI":"10.1016\/S2468-2667(23)00244-X","article-title":"Socioeconomic disparity in mortality and the burden of cardiovascular disease: analysis of the prospective urban rural epidemiology (PURE)-China cohort study","volume":"8","author":"Zhu","year":"2023","journal-title":"Lancet Public Health"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1016\/S0140-6736(24)01308-4","article-title":"Lipoprotein(a) and cardiovascular disease","volume":"404","author":"Nordestgaard","year":"2024","journal-title":"Lancet"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"2442","DOI":"10.1097\/CM9.0000000000002839","article-title":"Global and national burden of atherosclerosis from 1990 to 2019: trend analysis based on the global burden of disease study 2019","volume":"136","author":"Chen","year":"2023","journal-title":"Chin Med J"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1210\/en.2018-00591","article-title":"Impact of genes and environment on obesity and cardiovascular disease","volume":"160","author":"Heianza","year":"2019","journal-title":"Endocrinology"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"8817","DOI":"10.1038\/s41467-024-53236-y","article-title":"Disparities in high fasting plasma glucose-related cardiovascular disease burden in China","volume":"15","author":"Cao","year":"2024","journal-title":"Nat Commun"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/s40779-024-00569-w","article-title":"Global burden of benign prostatic hyperplasia, urinary tract infections, urolithiasis, bladder cancer, kidney cancer, and prostate cancer from 1990 to 2021","volume":"11","author":"Zi","year":"2024","journal-title":"Mil Med Res"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"102758","DOI":"10.1016\/j.eclinm.2024.102758","article-title":"Global, regional, and national burden of ischemic stroke, 1990-2021: an analysis of data from the global burden of disease study 2021","volume":"75","author":"Li","year":"2024","journal-title":"EClinicalMedicine."},{"key":"ref11","doi-asserted-by":"publisher","first-page":"2325","DOI":"10.1097\/CM9.0000000000003270","article-title":"Burden of non-communicable diseases in China and its provinces, 1990-2021: results from the global burden of disease study 2021","volume":"137","author":"Liu","year":"2024","journal-title":"Chin Med J"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"e19","DOI":"10.1016\/S0140-6736(16)30388-9","article-title":"Guidelines for accurate and transparent health estimates reporting: the GATHER statement","volume":"388","author":"Stevens","year":"2016","journal-title":"Lancet"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"2204","DOI":"10.1016\/S0140-6736(24)00685-8","article-title":"Burden of disease scenarios for 204 countries and territories, 2022-2050: a forecasting analysis for the global burden of disease study 2021","volume":"403","year":"2024","journal-title":"Lancet"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"102804","DOI":"10.1016\/j.eclinm.2024.102804","article-title":"Global, regional, and national burden of tracheal, bronchus, and lung cancer and its risk factors from 1990 to 2021: findings from the global burden of disease study 2021","volume":"75","author":"Kuang","year":"2024","journal-title":"EClinicalMedicine"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"e2334923","DOI":"10.1001\/jamanetworkopen.2023.34923","article-title":"Cardiovascular disease burden and outcomes among american indian and Alaska native medicare beneficiaries","volume":"6","author":"Eberly","year":"2023","journal-title":"JAMA Netw Open"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/s41569-021-00607-3","article-title":"Epidemiology of cardiovascular disease in Europe","volume":"19","author":"Townsend","year":"2022","journal-title":"Nat Rev Cardiol"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"101195","DOI":"10.1016\/j.lanwpc.2024.101195","article-title":"Burden of cardiovascular disease among the western pacific region and its association with human resources for health, 1990-2021: a systematic analysis of the global burden of disease study 2021","volume":"51","author":"Wang","year":"2024","journal-title":"Lancet Reg Health West Pac"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"100156","DOI":"10.1016\/j.lansea.2023.100156","article-title":"The burgeoning cardiovascular disease epidemic in Indians - perspectives on contextual factors and potential solutions","volume":"12","author":"Kalra","year":"2023","journal-title":"Lancet Reg Health"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"e137","DOI":"10.1212\/WNL.0000000000207387","article-title":"Global burden, risk factor analysis, and prediction study of ischemic stroke, 1990-2030","volume":"101","author":"Fan","year":"2023","journal-title":"Neurology"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"2380","DOI":"10.1161\/STROKEAHA.123.043131","article-title":"Global, regional, and national economic consequences of stroke","volume":"54","author":"Gerstl","year":"2023","journal-title":"Stroke"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1161\/STROKEAHA.116.014897","article-title":"Increased stroke burdens among the low-income young and middle aged in rural China","volume":"48","author":"Ning","year":"2017","journal-title":"Stroke"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"e897","DOI":"10.1016\/S2468-2667(21)00228-0","article-title":"Temporal trend and attributable risk factors of stroke burden in China, 1990-2019: an analysis for the global burden of disease study 2019","volume":"6","author":"Ma","year":"2021","journal-title":"Lancet Public Health"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"2086","DOI":"10.1161\/CIRCULATIONAHA.107.725101","article-title":"Gaps in public knowledge of peripheral arterial disease: the first national PAD public awareness survey","volume":"116","author":"Hirsch","year":"2007","journal-title":"Circulation"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"19898","DOI":"10.1038\/s41598-023-47028-5","article-title":"Global disease burden and its attributable risk factors of peripheral arterial disease","volume":"13","author":"You","year":"2023","journal-title":"Sci Rep"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1055\/s-0031-1278244","article-title":"Peripheral arterial disease: epidemiology, natural history, diagnosis and treatment","volume":"16","author":"Dhaliwal","year":"2007","journal-title":"Int J Angiol"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"3866","DOI":"10.21037\/jtd.2020.02.47","article-title":"Cardiovascular risk of smoking and benefits of smoking cessation","volume":"12","author":"Gallucci","year":"2020","journal-title":"J Thorac Dis"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"2523","DOI":"10.2337\/dc07-0282","article-title":"Diabetic nephropathy in 27,805 children, adolescents, and adults with type 1 diabetes: effect of diabetes duration, a1c, hypertension, dyslipidemia, diabetes onset, and sex","volume":"30","author":"Raile","year":"2007","journal-title":"Diabetes Care"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1001\/jamacardio.2023.4722","article-title":"Prioritizing the exposome to reduce cardiovascular disease burden","volume":"9","author":"Spatz","year":"2024","journal-title":"JAMA Cardiol"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"1308592","DOI":"10.3389\/fcvm.2024.1308592","article-title":"Association of sleep characteristics with cardiovascular disease risk in adults over 40 years of age: a cross-sectional survey","volume":"11","author":"Hou","year":"2024","journal-title":"Front Cardiovasc Med"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"12","DOI":"10.7554\/eLife.80560","article-title":"Phenome-wide mendelian randomization study of plasma triglyceride levels and 2600 disease traits","volume":"12","author":"Park","year":"2023","journal-title":"eLife"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.atherosclerosis.2022.08.018","article-title":"Modulatory role of gut microbiota in cholesterol and glucose metabolism: potential implications for atherosclerotic cardiovascular disease","volume":"359","author":"Roessler","year":"2022","journal-title":"Atherosclerosis"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1186\/s12916-023-02925-4","article-title":"Global, regional, and national burden of cardiovascular diseases in youths and young adults aged 15-39 years in 204 countries\/territories, 1990-2019: a systematic analysis of global burden of disease study 2019","volume":"21","author":"Sun","year":"2023","journal-title":"BMC Med"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1001\/jamacardio.2024.4115","article-title":"Pitavastatin, procollagen pathways, and plaque stabilization in patients with HIV: a secondary analysis of the REPRIEVE randomized clinical trial","volume":"10","author":"Kolossv\u00e1ry","year":"2025","journal-title":"JAMA Cardiol"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"1584","DOI":"10.1016\/j.jcmg.2023.08.006","article-title":"Coronary plaque characteristics associated with major adverse cardiovascular events in atherosclerotic patients and lesions: a systematic review and meta-analysis","volume":"16","author":"Gallone","year":"2023","journal-title":"JACC Cardiovasc Imaging"}],"container-title":["Frontiers in Public Health"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2025.1529506\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,26]],"date-time":"2025-06-26T00:10:45Z","timestamp":1750896645000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2025.1529506\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,26]]},"references-count":34,"alternative-id":["10.3389\/fpubh.2025.1529506"],"URL":"https:\/\/doi.org\/10.3389\/fpubh.2025.1529506","relation":{},"ISSN":["2296-2565"],"issn-type":[{"value":"2296-2565","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,26]]},"article-number":"1529506"}}